摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(氯甲基)-1H-噻吩并[3,4-d]咪唑 | 632334-68-0

中文名称
2-(氯甲基)-1H-噻吩并[3,4-d]咪唑
中文别名
——
英文名称
2-chloromethyl-1H-thieno[3,4-d]imidazole
英文别名
2-(chloromethyl)-1H-thieno[3,4-d]imidazole
2-(氯甲基)-1H-噻吩并[3,4-d]咪唑化学式
CAS
632334-68-0
化学式
C6H5ClN2S
mdl
MFCD18810582
分子量
172.638
InChiKey
YJDRLCROQGISEE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.166
  • 拓扑面积:
    56.9
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] INHIBITORS TARGETING DRUG-RESISTANT INFLUENZA A<br/>[FR] INHIBITEURS CIBLANT LA GRIPPE A PHARMACORÉSISTANTE
    申请人:UNIV PENNSYLVANIA
    公开号:WO2013086131A1
    公开(公告)日:2013-06-13
    Provided are compounds according to formula (la) or (lb) as described herein, that are capable of modulating the activity of influenza viruses (e.g., influenza A virus), for example, via interaction with the M2 transmembrane protein, and other similar viroporins. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a composition comprising one or more compounds according to according to formulas (la') or (lb), as described herein.
    根据本文描述的公式(la)或(lb),提供了一些化合物,这些化合物能够调节流感病毒(例如流感A病毒)的活性,例如通过与M2跨膜蛋白以及其他类似的病毒孔蛋白相互作用。还提供了一种治疗流感A感染疾病状态或感染的方法,包括通过给予包含根据本文描述的公式(la')或(lb)的一个或多个化合物的组合物进行治疗。
  • Fused Bicyclic Aromatic Compounds that are Useful in Treating Sexual Dysfunction
    申请人:Cowart D. Marlon
    公开号:US20070265249A1
    公开(公告)日:2007-11-15
    The present invention relates to the use of compounds of formula (I) for the treatment of sexual dysfunction and to compositions containing compounds of formula (I) for the treatment of sexual dysfunction, wherein A, L, D and B 1 are as described in the specification.
    本发明涉及使用式(I)化合物治疗性功能障碍以及含有式(I)化合物的组合物治疗性功能障碍,其中A、L、D和B1如说明书所述。
  • INHIBITORS TARGETING DRUG-RESISTANT INFLUENZA A
    申请人:THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    公开号:US20150191439A1
    公开(公告)日:2015-07-09
    Provided are compounds according to formula (Ia) or (Ib) as described herein, that are capable of modulating the activity of influenza viruses (e.g., influenza A virus), for example, via interaction with the M2 transmembrane protein, and other similar viroporins. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a composition comprising one or more compounds according to according to formulas (Ia′) or (Ib), as described herein.
    提供了符合公式(Ia)或(Ib)的化合物,可以通过与M2跨膜蛋白和其他类似的病毒孔蛋白相互作用,调节流感病毒(例如流感A病毒)的活性。还提供了一种治疗流感A受影响的疾病状态或感染的方法,包括给予含有一个或多个符合公式(Ia′)或(Ib)的化合物的组合物。
  • US7057042B2
    申请人:——
    公开号:US7057042B2
    公开(公告)日:2006-06-06
  • US7235661B2
    申请人:——
    公开号:US7235661B2
    公开(公告)日:2007-06-26
查看更多

同类化合物

沙维拉唑 4H-吡咯并[1,2-a]噻吩并[3,2-D]咪唑 3H-噻吩并[2,3-d]咪唑-5-羧酸 3-甲基-1H-噻吩并[2,3-d]咪唑-2(3h)-酮 2-(氯甲基)-1H-噻吩并[3,4-d]咪唑 1H-噻吩并[3,2-D]咪唑-2(3H)-酮 1H-噻吩并[2,3-d]咪唑,1-乙烯基-(9CI) 1H-噻吩并(3,4-d)咪唑,2-(((5-甲基-2-吡啶基)甲基)亚硫酰基)- 1-甲基-1H-噻吩并[2,3-D]咪唑基-2(3H)-酮 1-乙烯基-1H-噻吩并[2,3-d]咪唑-5-羧酸 1,3-二氢噻吩并[3,4-d]咪唑-2-硫酮 tert-butyl 4-[4-(2,3-dihydro-2-oxo-1-tert-butoxycarbonyl-1H-thieno[3,4-d]imidazol-4-yl)phenyl]-2,3-dihydro-2-oxo-1H-thieno[3,4-d]imidazole-1-carboxylate 2-(3-Bromo-4-methoxy-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-[3-Methoxy-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethylsulfanyl]-1H-thieno[3,4-d]imidazole 2-(2-diethylaminobenzylmercapto)-1H-thieno[3,4-d]imidazole 2-(5-Bromo-4-methoxy-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-(5-Chloro-4-methoxy-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-(2-dimethylaminobenzylmercapto)-1H-thieno[3,4-d]imidazole 6-amino-1-vinylthieno[2,3-d]imidazole-5-carboxamide 1-Vinyl-1H-thieno[2,3-d]imidazole-5-carboxylic acid ethyl ester 2-(3-Chloro-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 2-(5-Methoxy-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole (2S,4S)-tert-butyl 2-(5-(4-bromophenyl)-1H-thieno[2,3-d]imidazol-2-yl)-4-methylpyrrolidine-1-carboxylate 1-methyl-2-methoxymethyl-thieno[2.3-d]imidazol-5-yl-carboxylic acid 2-(3-Fluoro-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 2-(4-Benzyloxy-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 2-(4-methoxy-2-picolylsulfinyl)-1H-thieno[3,4-d]imidazole 2-[(4-methoxypyridin-2-yl)methylsulfinyl]-1H-thieno[2,3-d]imidazole 4-(4-methoxyphenyl)-2-[(4-methoxypyridin-2-yl)methylsulfinyl]-1H-thieno[3,4-d]imidazole 2-(4-methoxy-2-picolylmercapto)-1H-thieno[3,4-d]imidazole methyl 2-[(4-methoxypyridin-2-yl)methylsulfanyl]-1H-thieno[3,4-d]imidazole-4-carboxylate 2-[(4-methoxypyridin-2-yl)methylsulfinyl]-4-phenyl-1H-thieno[3,4-d]imidazole dimethyl 2-[(4-methoxypyridin-2-yl)methylsulfinyl]-1H-thieno[2,3-d]imidazole-5,6-dicarboxylate 2-[(4-methoxypyridin-2-yl)methylsulfanyl]-1H-thieno[2,3-d]imidazole methyl 2-[(4-methoxypyridin-2-yl)methylsulfinyl]-1H-thieno[3,4-d]imidazole-4-carboxylate 1-Ethoxycarbonyl-2-(4-methoxy-2-picolylsulfinyl)-1H-thieno[3,4-d]imidazole 1-ethoxycarbonyl-2-(4-methoxy-2-picolylmercapto)-1H-thieno[3,4-d]imidazole ethyl 2-methylthieno[2,3-d]imidazol-5-carboxylate 2-[(5-chloropyridin-2-yl)methylsulfinyl]-1H-thieno[3,4-d]imidazole 2-[(4-Thiazolyl)methylthio]thieno[3,4-d]imidazole 2-[[3-Methoxy-4-(2,2,3,3,4,4,4-heptafluorobutoxy)-2-pyridinyl]methylsulfinyl]-1H-thieno[3,4-d]imidazole 2-[(3-methoxypyridin-2-yl)methylsulfinyl]-1H-thieno[3,4-d]imidazole 2-[(3,4-dimethoxypyridin-2-yl)methylsulfanyl]-1H-thieno[3,4-d]imidazole 2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-thieno[3,4-d]imidazole 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-4-(4-methoxyphenyl)-1H-thieno[3,4-d]imidazole 2-(4-methoxy-3,5-dimethyl-2-picolylsulfinyl)-1H-thieno[3,4-d]imidazole 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-4-phenyl-1H-thieno[3,4-d]imidazole 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-1H-thieno[3,4-d]imidazole (3S,3'S,5S,5'S)-tert-butyl 5,5'-(5,5'-(buta-1,3-diyne-1,4-diyl)bis(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-thieno[2,3-d]imidazole-5,2-diyl))bis(3-methylpyrrolidine-1-carboxylate) (2S,4S)-tert-butyl 2-(5-ethynyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-thieno[2,3-d]imidazol-2-yl)-4-methylpyrrolidine-1-carboxylate